1Zadrozny M,Smolarz B,Romanowicz-Makowska H,etal.Genetic analysis of HER-2/neu gene amplification inparaffin embedded tumour tissue in women with breast can-cer[J].Pol J Pathol,2002,53(4):189-193. 被引量：1
5Bollig A,Miksicek R J.An estrogen receptor-alpha splic-ing variant mediates both positive and negative effects ongene transcription[J].Mol Endocrinol,2000,14(5):634-649. 被引量：1
6Gwinn M R,Leonard S S,Sargent L M,et al.The role ofp53 in silica-induced cellular and molecular responses asso-ciated with carcinogenesis[J].J Toxicol Environ Health A,2009,72(23):1509-1519. 被引量：1
7Ranade K J,Nerurkar A V,Phulpagar M D,et al.Ex-pression of survivin and p53 proteins and their correlationwith hormone receptor status in Indian breast cancer pa-tients[J].Indian J Med Sci,2009,63(11):481-490. 被引量：1
8Bollig A , Miksicek RJ. An estrogen receptor-or splicing variant mediates both positive and negative effects on gene transcription[J]. Molecular Endocrinology, 2000,14(5) :634-649. 被引量：1
9Ohlsson H, Lykkesfeldt AE, Madsen MW, et al. The estrogen receptor variant lacking exon 5 has dominant negative activity in the human breast epithelial cell line HMT-3522S1 [J]. Cancer Research, 1998,58(19): 4264-4268. 被引量：1
10Fuqua SA, Allred DC, Elledge RM, et al. The ER-positive/PgRnegative breast cancer phenotype is not associated with mutations within the DNA binding domain [J]. Breast Cancer Research and treatment, 1993,26(2) : 191-202. 被引量：1
